| P2093 | author name string | C. F. Scott | |
| | S. Silver | |
| | K. Weinhold | |
| | A. Langlois | |
| | J. E. Robinson | |
| | S. D. Putney | |
| | A. T. Profy | |
| P2860 | cites work | Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 |
| | Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 |
| | The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 |
| | Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. | Q30355613 |
| | Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections | Q33365763 |
| | Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides | Q33560772 |
| | Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120 | Q33571605 |
| | Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees | Q33582665 |
| | Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120 | Q33632668 |
| | Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV | Q33649062 |
| | Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual | Q33671780 |
| | Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome | Q33681857 |
| | Generation of human monoclonal antibodies to human immunodeficiency virus | Q33841011 |
| | Mouse/human chimeric monoclonal antibody in man: kinetics and immune response | Q33867651 |
| | Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. | Q34214455 |
| | Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein | Q34301897 |
| | Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins | Q35076867 |
| | Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120 | Q36832017 |
| | Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope | Q36869394 |
| | Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1 | Q36872993 |
| | Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques | Q36952733 |
| | Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection | Q37217308 |
| | NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection | Q38197651 |
| | Characterization of HIV-1 neutralization escape mutants | Q38342986 |
| | NIH conference. The acquired immunodeficiency syndrome: an update | Q39494050 |
| | Expression of the HTLV-III envelope gene by a recombinant vaccinia virus | Q39500655 |
| | HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex | Q41379235 |
| | Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell Lines | Q41736501 |
| | Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals | Q43691530 |
| | Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual | Q44298917 |
| | Antibody to lymphadenopathy-associated virus in AIDS. | Q44502165 |
| | Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein | Q44509170 |
| | An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies | Q44522722 |
| | Neutralizing monoclonal antibodies to the AIDS virus | Q44940572 |
| | Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant | Q45018234 |
| | Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. | Q45839741 |
| | Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus. | Q45847796 |
| | HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope | Q45848174 |
| | Envelope sequences of two new United States HIV-1 isolates | Q48321674 |
| | Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. | Q55242478 |
| | HIV-specific cytotoxic T lymphocytes in seropositive individuals | Q59098667 |
| | Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals | Q69916267 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| | monoclonal antibody | Q422248 |
| | antibody-dependent cellular cytotoxicity | Q21418091 |
| P304 | page(s) | 8597-8601 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain | |
| P478 | volume | 87 | |